Annals of internal medicine

• Latest
• Best
• Search…

• Ann. Intern. Med. · Mar 2022

  Comment

  In advanced CKD with poorly controlled hypertension, chlorthalidone reduced BP at 12 wk.

  Agarwal R, Sinha AD, Cramer AE, et al. Chlorthalidone for hypertension in advanced chronic kidney disease. N Engl J Med. 2021;385:2507-19. 34739197.

  explore further… mark as read…

• Ann. Intern. Med. · Mar 2022

  Comment

  In older adults, use of a recombinant zoster vaccine was associated with Guillain-Barré syndrome.

  Goud R, Lufkin B, Duffy J, et al. Risk of Guillain-Barré syndrome following recombinant zoster vaccine in Medicare beneficiaries. JAMA Intern Med. 2021;181:1623-30. 34724025.

  read on… or not…

• Ann. Intern. Med. · Mar 2022

  Comment

  In type 2 diabetes with increased CV risk, tirzepatide reduced HbA1c vs. glargine at 52 wk.

  Del Prato S, Kahn SE, Pavo I, et al. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Lancet. 2021;398:1811-24. 34672967.

  keep reading… or just mark as read…

• Ann. Intern. Med. · Mar 2022

  Comment

  In CV disease, GLP-1 RAs and SGLT2 inhibitors reduce CV mortality.

  Kanie T, Mizuno A, Takaoka Y, et al. Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis. Cochrane Database Syst Rev. 2021;10:CD013650. 34693515.

  keep reading… or just mark as read…

• Ann. Intern. Med. · Mar 2022

  Letter Case Reports

  An Electrocardiographic Artifact Synchronized With the Cardiac Rhythm: A Case Report.

  no abstract available

  read more… mark as read…